SARS-CoV-2 Nucleoprotein CTD Domain
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleoprotein CTD Domain is a recombinant protein expressed in E. coli.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx163975-50UG |
| Pricing | 50 µg USD $304.5 |
| Conjugation | Unconjugated |
| Host | E. coli |
| Tested Applications | ELISA, WB, SDS-PAGE |
| Dry Ice | No |
| Availability | Shipped within 7-12 working days. |
| Note | This product is for research use only. |